EARLY CARCINOMA ANTIGENS/ CANCER MARKERS IN ONCOLOGY/ SURFACE PROTEASE ANTIGE

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 本研究的目的是在组织、血液和体液中寻找新的癌症标志物(前列腺癌、结肠癌、乳腺癌、卵巢癌、肺癌、头颈癌、脑癌、胰腺癌、膀胱癌、肾癌、睾丸癌和其他癌症)。新的标记物可能允许我们开发实验室测试，可以更早地诊断癌症和/或识别有不良预后风险的患者，并可能从比通常推荐的常规护理更积极的治疗中受益。癌症患者和正常、健康的人都将参与这项研究。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to look for new cancer markers (prostate, colon, breast, ovarian, lung, head-neck, brain, pancreas, bladder, kidneys, testis, and other carcinoma cancers) in the tissue, blood, and body fluids. New markers may allow us to develop laboratory tests which can diagnose cancers earlier and/or identify patients who are at risk for a poor outcome amd may benefit from more aggressive therapy than is normally reccomended for routine care. Both cancer patients and normal, healthy individuals who will participate in this study.